|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
N/A
|
(NCI)
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Quantitative Radiomics System Decoding the Tumor Phenotype
|
5U24CA194354-04
|
$683,694
|
AERTS, HUGO
|
DANA-FARBER CANCER INST
|
|
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer
|
1R01CA213996-01A1
|
$343,125
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Assessment of sensory gating, attention, and executive control in breast cancer
|
1R01CA218496-01A1
|
$687,576
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Advancing the translatability of mouse models for cancer immunotherapy
|
1R01CA210561-01A1
|
$587,737
|
AKHURST, ROSEMARY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Quantitative MRI Radiomics of Breast Cancer in Assessment of Malignancy and Response to Therapy
|
1F31CA221193-01A1
|
$26,048
|
ANTROPOVA, NATALIA
|
UNIVERSITY OF CHICAGO
|
|
HER2-pretargeting image-guided therapy of breast cancer
|
5R01CA209884-02
|
$393,896
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIABC011004
|
$154,897
|
Avital, Itzhak
|
CCR (NCI)
|
|
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
|
1R37CA215427-01A1
|
$352,275
|
AZMI, ASFAR
|
WAYNE STATE UNIVERSITY
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
7T Neurosurgical Mapping Protocol for Endoscopic Resection of Skull Base Tumors
|
5R01CA202911-03
|
$387,731
|
BALCHANDANI, PRITI
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Structure, Function, and Inhibition of the RhoGEF Trio - a Target in Uveal Melanoma
|
1F31CA224804-01A1
|
$35,917
|
BANDEKAR, SUMIT
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Functional Significance of CD133 in Pancreatic Cancer
|
5R01CA184274-05
|
$318,513
|
BANERJEE, SULAGNA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Metabolic and signaling control of tumorformation in drosophila
|
5R01CA217608-28
|
$352,275
|
BANERJEE, UTPAL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Functional Inhibition of Deubiquitylase HAUSP to Disrupt Glioblastoma Stem Cells
|
5R01CA184090-04
|
$362,569
|
BAO, SHIDENG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Mapping druggable co-dependency pathways in NRF2-driven lung cancers
|
5K99CA215249-02
|
$114,750
|
BAR-PELED, LIRON
|
SCRIPPS RESEARCH INSTITUTE
|
|
Fundamental subcortical mechanisms of affective processing
|
5U01CA193632-03
|
$350,973
|
BARRETT, LISA
|
NORTHEASTERN UNIVERSITY
|
|
The Role of RHOA in Diffuse Gastric Cancer
|
1R01CA224428-01
|
$677,302
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
MD Anderson Cancer Center EDRN- CVC for Early Detection of Ovarian Cancer
|
5U01CA200462-03
|
$910,580
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-11
|
$5,000
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
MIC-1 and its functional partners in prostate cancer racial disparity
|
5U01CA185148-04
|
$312,080
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
Identifying the Molecular and Cellular Basis of Invasive Phenotype in Human DCIS
|
5R01CA207445-02
|
$571,242
|
BEHBOD, FARIBA
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Dietary fats, mitochondrial function and muscle health in cancer patients
|
1R21CA209566-01A1
|
$199,655
|
BELURY, MARTHA
|
OHIO STATE UNIVERSITY
|
|
Investigating the Relationship Between Racial Residential Segregation and Hepatocellular Carcinoma
|
1F30CA216947-01A1
|
$49,524
|
BEMANIAN, AMIN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Influence of Exercise on Neurocognitive Function in Breast Cancer
|
5R01CA196762-03
|
$607,082
|
BENDER, CATHERINE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Investigating the role of the mitochondrial pyruvate carrier in colon tumorigenesis
|
1F30CA225110-01
|
$44,061
|
BENSARD, CLAIRE
|
UNIVERSITY OF UTAH
|
|
Early Detection of Hepatocellular Carcinoma
|
5R01CA195524-03
|
$644,934
|
BERETTA, LAURA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Pediatric Oncology Research Training Program
|
5T32CA009351-40
|
$250,143
|
BERNSTEIN, IRWIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-05
|
$8,073,787
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
BET protein antagonist-based targeted therapy of Mantle Cell Lymphoma
|
5R01CA210250-02
|
$390,134
|
BHALLA, KAPIL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Reversing/Blocking T cell suppression by extracellular vesicles as cancer therapy
|
1R43CA224602-01A1
|
$280,928
|
BHATTA, MAULASRI
|
IMMUNE MODULATORY THERAPIES, LLC
|
|
COMPREHENSIVE CANCER CENTER CORE SUPPORT GRANT
|
5P30CA013148-46
|
$5,104,077
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Crosstalk of LKB1 and KEAP1 mutations in driving growth of lung adenocarcinoma
|
5R01CA206155-03
|
$395,755
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Improving Physical Functioning in Older Cancer Survivors Through Light-Intensity Physical Activity
|
1K07CA215937-01A1
|
$154,707
|
BLAIR, CINDY
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Pediatric Oncology Clinical Research Training Program
|
5K12CA090433-17
|
$827,164
|
BLANEY, SUSAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-05
|
$8,625,592
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Virtual Transportation as a Strategy to Reduce Resistance to Cigarette and e-Cigarette Graphic Health Warnings in Adolescents and Young Adults
|
5R01CA214587-03
|
$363,195
|
BLANTON, HART
|
TEXAS A&M UNIVERSITY
|
|
The Breast Cancer and the Workforce Communication App: A randomized controlled trial of an English/Spanish intervention to promote long-term job retention
|
1R37CA214785-01A1
|
$730,499
|
BLINDER, VICTORIA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Alternatively Spliced Tissue Factor and Pathobiology of Pancreatic Cancer
|
5R01CA190717-04
|
$276,298
|
BOGDANOV, VLADIMIR
|
UNIVERSITY OF CINCINNATI
|
|
A Unique Class of Reductively Activated Oncology Drugs
|
5R01CA208669-02
|
$718,986
|
BOGER, DALE
|
SCRIPPS RESEARCH INSTITUTE
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Breast CT: Final Steps to Translation
|
5R01CA181081-04
|
$559,655
|
BOONE, JOHN
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor-selective radiosensitization of NSCLC using NQO1 bioactivatable drugs
|
1R01CA224493-01
|
$347,128
|
BOOTHMAN, DAVID
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|